GenScript's advances in gene editing, bi-specific antibodies and mRNAs

About

This session will present the latest biotech innovations that are revolutionising biomedical R&D and will be designed for researchers looking to move forward with agile, robust, and future-ready technologies.  The following topics will be discussed:

• Advanced gene editing: the use of technologies such as Prime Editing, an evolution of traditional CRISPR, which allows precise genome edits without generating double-strand breaks, ideal for safer therapeutic applications, will be addressed.
• Bi-specific antibodies: Discover how our TurboCHO™ platform enables accelerated and efficient expression of complex antibodies, optimising the development of next-generation immunotherapies and biologics.
• In vitro mRNA production: Finally, explore GenScript's solutions for customised mRNA synthesis, from research to pre-clinical batches, with guaranteed quality and fast delivery.

Bio

Juliana Campo has a background in neurobiology and immunology, where she focused on the characterization of regenerative niches in the adult brain and investigated the effects of invading immune cells on neural stem cells.

Since joining GenScript as a Field Application Scientist, she has specialized in RNA and CRISPR technologies, expanding her knowledge base to provide expert technical support to customers.